• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT261414
Device Problem Material Invagination (1336)
Patient Problem No Code Available (3191)
Event Date 09/27/2018
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing records verified that the lot involved in this event met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), complications associated with the use of the gore® excluder® aaa endoprosthesis may include but are not limited to: surgical conversion.The gore® excluder® trunk-ipsilateral leg component rlt261414/17535686 was explanted and discarded at the facility.Therefore, an engineering evaluation could not be performed.
 
Event Description
The following information was reported to gore: on (b)(6) 2019, this patient underwent endovascular abdominal repair and was treated with gore® excluder® aaa endoprostheses.On an unknown date, the patient returned to the hospital with back pain.On (b)(6) 2018, computed tomography imaging revealed an infolding of the proximal end of the gore® excluder® trunk-ipsilateral leg component rlt261414.The physician was unable to identify a cause as there were no obvious issues relating neither to the device, nor to pre-planning considerations or intra-operative manoeuvers.Reportedly, the patient¿s aortic neck was mildly angulated and showed a slight reverse taper.The condition was stated to have been the only anatomical difficulty.Also on (b)(6) 2018, and as a preventive measure, all gore® excluder® aaa endoprostheses were explanted.The patient tolerated the procedure.
 
Manufacturer Narrative
Describe event or problem: corrected date of initial implant from (b)(6) 2018.
 
Event Description
On (b)(6) 2018, this patient underwent endovascular abdominal repair and was treated with gore® excluder® aaa endoprostheses.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8425526
MDR Text Key138956815
Report Number3007284313-2019-00075
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132622450
UDI-Public00733132622450
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/09/2020
Device Catalogue NumberRLT261414
Device Lot Number17535686
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/15/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
Patient Weight88
-
-